KATHRYN BACHMAN: Open Payments
NPI 1225427040 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 42 payments from 9 companies in 2025. Trend: 2023 $713 · 2024 $879 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $161 |
| Amgen Inc. | 14 | $140 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Philips North America LLC | 1 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: REPATHA, ELIQUIS, LifeVest, VYNDAQEL, FARXIGA, Extended Holter, Assure WCD, EUFLEXXA.
Industry payments across OK — which companies pay providers there.
